Using TENS to relieve menstrual pain in women
Determining the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Menstrual Symptoms in Primary Dysmenorrhea
This study is testing if a device that sends gentle electrical pulses can help women with severe menstrual pain feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 93 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Osmaniye Korkut Ata University Academic / other |
| Locations | 1 site (Osmaniye) |
| Trial ID | NCT06741059 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in managing pain and alleviating symptoms associated with primary dysmenorrhea. Primary dysmenorrhea is characterized by severe menstrual pain that can significantly impact daily life. The study will apply TENS, a non-invasive method that uses electrical impulses to stimulate nerves, to evaluate its impact on menstrual pain intensity and related symptoms. The goal is to determine whether TENS can serve as an alternative or complementary treatment option for women suffering from this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and above with regular menstrual cycles and moderate to severe dysmenorrhea pain.
Not a fit: Patients with secondary dysmenorrhea, those using oral contraceptives, or individuals with certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive and drug-free option for managing menstrual pain in women.
How similar studies have performed: Previous studies have shown promising results for TENS in pain management, suggesting potential effectiveness for menstrual pain, although this specific application may be less explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 and above * Have regular menstrual cycles (lasting 3 to 8 days, with a menstrual cycle range of 21 to 35 days) * Have dysmenorrhea pain severity rated 4 or higher on the Visual Analog Scale (VAS) Exclusion Criteria: Women with the following conditions were excluded from the study: * Secondary dysmenorrhea * Using oral contraceptives * Having impaired tissue integrity in the abdominal area * Having previous experience with TENS * Having a history of nerve damage or sensory loss * Having a pacemaker * Having any systemic diseases * Being pregnant or in the postpartum period
Where this trial is running
Osmaniye
- Esra Ünal — Osmaniye, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Esra U Unal, Doctor
- Email: esraunal2428@gmail.com
- Phone: +905342878405
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.